Ligand validation:6BQH

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BQH_OLC_A_1207	20%	97%	0.197	0.931	0.2	0.12	-	-	0	0	28%	0.28
6BQH_OLC_A_1203	20%	94%	0.17	0.855	0.24	0.22	-	-	0	0	52%	0.52
6BQH_OLC_A_1204	16%	95%	0.222	0.867	0.24	0.18	-	-	0	0	60%	0.6
6BQH_OLC_A_1205	10%	95%	0.214	0.818	0.23	0.17	-	-	0	0	48%	0.48
6BQH_OLC_A_1206	3%	93%	0.408	0.821	0.23	0.24	-	-	0	0	56%	0.56
6BQH_OLC_A_1202	1%	92%	0.388	0.656	0.28	0.23	-	-	0	0	76%	0.76
6BQG_OLC_A_1202	26%	57%	0.163	0.902	0.42	1.2	-	1	0	0	44%	0.44
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.